Amphiphilic star-like macromolecules as novel carriers for topical delivery of nonsteroidal anti-inflammatory drugs

被引:0
|
作者
Djordjevic, J
Michniak, B
Uhrich, KE
机构
[1] Rutgers State Univ, Dept Chem & Biol Chem, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, Piscataway, NJ 08854 USA
[3] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA
来源
AAPS PHARMSCI | 2003年 / 5卷 / 04期
关键词
topical drug delivery; NSAIDs; polymeric micelle; permeation; drug release;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to evaluate amphiphilic star-like macromolecules (ASMs) as a topical drug delivery system. Indomethacin, piroxicam, and ketoprofen were individually encapsulated into the ASMs using coprecipitation. The effects of the ASMs on percutaneous permeation of nonsteroidal anti-inflammatory drugs (NSAIDs) across full thickness, hairless mouse skin were evaluated in vitro using modified Franz diffusion cells. In addition, solubility and in vitro release experiments were performed to characterize ASMs behavior in aqueous media. Poly(ethylene glycol) (PEG) and Pluronic P-85 were used as polymer controls to compare the role of PEG and amphiphilic behavior in the ASMs. In vitro release experiments indicated that ASMs can delay drug release (P <.05), whereas solubility measurements showed that ASMs can increase NSAIDs aqueous solubility (P <.05). Percutaneous permeation studies revealed that ASMs decreased both flux and Q(24) of drugs compared with the control (P <. 10). Skin pretreatment studies with ASM-containing solution before drug application demonstrated that pretreatment similarly influenced NSAID percutaneous permeation. In conclusion, ASMs likely slow drug permeation through 2 mechanisms, delayed drug diffusion from its core and skin dehydration by its shell. Thus, ASMs may be useful for delayed dermal delivery or prevention of compound permeation through the skin (eg, sunscreens, N,N-diethyl-m-toluamide [DEET]) from aqueous formulations.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Topical Nonsteroidal Anti-Inflammatory Drugs for Chronic Musculoskeletal Pain in Adults
    McVeigh, Helen
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2013, 17 (04) : 447 - 448
  • [22] Topical nonsteroidal anti-inflammatory drugs for ophthalmic use - A safety review
    Gaynes, BI
    Fiscella, R
    DRUG SAFETY, 2002, 25 (04) : 233 - 250
  • [23] Topical Nonsteroidal Anti-Inflammatory Drugs for Ophthalmic UseA Safety Review
    Bruce I. Gaynes
    Richard Fiscella
    Drug Safety, 2002, 25 : 233 - 250
  • [24] Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs
    Guidera, AC
    Luchs, JI
    Udell, IJ
    OPHTHALMOLOGY, 2001, 108 (05) : 936 - 944
  • [25] Topical Nonsteroidal Anti-Inflammatory Drugs for Chronic Musculoskeletal Pain in Adults
    Wall, Danette Y.
    ORTHOPAEDIC NURSING, 2017, 36 (02) : 161 - 163
  • [26] Osteoarthritis guidelines: a progressive role for topical nonsteroidal anti-inflammatory drugs
    Stanos, Steven P.
    JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2013, 6 : 133 - 137
  • [27] Don't Forget the Topical Nonsteroidal Anti-inflammatory Drugs ( NSAIDs)
    Jafari, Golriz
    Pham, Phuong-Chi T.
    Nguyen, Hoang Anh
    Gopal, Sapna
    Chandra, Anirudh Vijay
    Kamarzarian, Anita
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [28] Action of β-endorphin and nonsteroidal anti-inflammatory drugs, and the possible effects of nonsteroidal anti-inflammatory drugs on β-endorphin
    Luan, Yuan-Hang
    Wang, Di
    Yu, Qi
    Chai, Xiao-Qing
    JOURNAL OF CLINICAL ANESTHESIA, 2017, 37 : 123 - 128
  • [29] Nonsteroidal anti-inflammatory drugs and the gut
    Hirschowitz, BI
    SOUTHERN MEDICAL JOURNAL, 1996, 89 (03) : 259 - 263
  • [30] Nonsteroidal anti-inflammatory drugs for dysmenorrhoea
    Marjoribanks, Jane
    Ayeleke, Reuben Olugbenga
    Farquhar, Cindy
    Proctor, Michelle
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (07):